News

November 16, 2021 - Imaging Endpoints (IE) announced today that it has formally established Caring Endpoints, a new wholly-owned non-profit subsidiary to support its employees and the community at large. Caring Endpoints is designed to leverage the resources and expertise…   Read More

November 9, 2021 - Primary liver cancer or hepatocellular carcinoma (HCC) is the most common form of liver cancer accounting for more than 90% of all cases. HCC represents a major global health challenge as its incidence continues to rise…   Read More

October 28, 2021 - Imaging Endpoints’ Chief Medical Officer Ron Korn, MD, PhD., will join the ongoing CTISUS Facebook Live series to discuss “Challenges and Opportunities For Evaluating Radiologic Treatment Responses in the Era of Immunotherapy” today at 3 p.m.…   Read More

October 27, 2021 - In clinical trial work, determining whether a tumor is truly responding in a study is a very real concern. Imaging Endpoints’ Chief Medical Officer Ron Korn, MD. PhD. will discuss this concern and how certain imaging…   Read More

October 27, 2021 - Imaging Endpoints announced today that it has established a new office in Shanghai, China. Imaging Endpoints has strategically opened offices around the world to provide its real-time services as efficiently as possible while working more closely…   Read More

October 12, 2021 - Breast cancer is the most aggressive cancer in women and the second leading cause of cancer death, other than lung cancer, for women. Worldwide, breast cancer is now (as of 2021) the most common cancer globally…   Read More

October 5, 2021 - Ovarian Cancer encompasses cancers of ovaries, fallopian tubes, and the primary peritoneum, which is the tissue that lines the abdominal wall and covers the abdominal organs. These cancers often go undetected until they've reached advanced stages.…   Read More

October 4, 2021 - Imaging Endpoints congratulates Kite, a Gilead Company (Nasdaq: GILD), on its submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Yescarta® (axicabtagene ciloleucel), based on data from its…   Read More

September 28, 2021 - Imaging Endpoints – in collaboration with Daniel D. Von Hoff, Taylor Brodie, Derek Cridebring and Michael J. Demeure – is presenting at the American Association for Cancer Research’s Pancreatic Cancer Virtual Special Conference September 29-30, 2021.…   Read More

September 23, 2021 - The Imaging Endpoints team works passionately every day to Connect Imaging to the Cure™ and in doing so has helped to bring numerous new, life-saving treatments to humanity. As the largest oncology-focused global iCRO, Imaging Endpoints…   Read More